Concepedia

Chung Hyo Kang

CH

9

Publications

399

Citations

9

H-Index

2016

Active since

Affiliations

Chungnam National University(Current)

Korea Research Institute of Chemical Technology

Korea University of Science and Technology

Seoul National University

Bank of Korea

Chung Hyo Kang is an author at Chungnam National University specializing in medicine, cell biology, and immunotherapy.

ORCID

Top concepts

Publications per year

2016–2023

9

Publications

9

Induced protein degradation of anaplastic lymphoma kinase (ALK) by proteolysis targeting chimera (PROTAC)

Chung Hyo Kang, Dong-Ho Lee, Chong Ock Lee et al. · Biochemical and Biophysical Research Communications · 2018 · 117 citations

, , +8

Folate receptor 1 (FOLR1) targeted chimeric antigen receptor (CAR) T cells for the treatment of gastric cancer

Minsung Kim, Suhkneung Pyo, Chung Hyo Kang et al. · PLoS ONE · 2018 · 95 citations · Full text

, , +16

A Chemical Switch System to Modulate Chimeric Antigen Receptor T Cell Activity through Proteolysis-Targeting Chimaera Technology

So Myoung Lee, Chung Hyo Kang, Sang Un Choi et al. · ACS Synthetic Biology · 2020 · 48 citations

, , +18

Disordered region of cereblon is required for efficient degradation by proteolysis-targeting chimera

Kidae Kim, Dong-Ho Lee, Sungryul Park et al. · Scientific Reports · 2019 · 36 citations · Full text

c-Met-Specific Chimeric Antigen Receptor T Cells Demonstrate Anti-Tumor Effect in c-Met Positive Gastric Cancer

Chung Hyo Kang, Yeongrin Kim, Da Yeon Lee et al. · Cancers · 2021 · 35 citations · Full text

, , +24

Rows per page

1–5 of 9